Concepedia

Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke

Manuel Cappellari, Giuseppe Moretto, Nicola Micheletti, Francesco Donato, Giampaolo Tomelleri, Giosué Gulli, Monica Carletti, Giovanna Squintani, Tiziano Zanoni, Sarah Ottaviani,

Journal of Thrombosis and Thrombolysis · 2013 · 20 citations · 20 references

DOI

Concepts

References

20

Tissue Plasminogen Activator for Acute Ischemic Stroke

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group · New England Journal of Medicine · 1995 · 11.7K citations

, , +17

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

Werner Hacke, Markku Kaste, Erich Bluhmki et al. · New England Journal of Medicine · 2008 · 6.6K citations · Full text

, , +11

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study

Nils Wahlgren, Niaz Ahmed, Antoni Dávalos et al. · The Lancet · 2007 · 2.4K citations

, , +13

Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator

Gregory J. del Zoppo, Jeffrey L. Saver, Edward C. Jauch et al. · Stroke · 2009 · 825 citations · Full text

, , +14

Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study

Nils Wahlgren, Niaz Ahmed, Antoni Dávalos et al. · The Lancet · 2008 · 569 citations

, , +11